Company / Interest Expense per Share
Centessa Pharmaceuticals plc Interest Expense per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.10
FY2023
5-year range
$0.08 / $0.10
FY2022-FY2023
Trend
+34.1%
vs FY2022
Sector context
#25 of 45
Health Care
What the data says
At $0.10, Centessa Pharmaceuticals plc's interest expense per share ranks #21 of 45 in the Health Care sector.
Based on SEC 10-K filings.
0.10 in FY2023.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#21 of 45 in Health CareTop 44% of 45This company $0.10 Sector average $17.79
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 34.1% year-over-year.
- Ranks #25 out of 45 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.10 | +34.1% |
| FY2022 | $0.08 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026